Levitt G A, Yeomans E, Dicks Mireaux C, Breatnach F, Kingston J, Pritchard J
Department of Haematology, Hospital for Sick Children, London, UK.
Br J Cancer. 1992 Nov;66(5):877-82. doi: 10.1038/bjc.1992.378.
Now that most patients with Wilms' tumour are cured, it is practicable to study the long-term morbidity of their treatment and use this information to reduce treatment sequelae in the future. In this study we evaluate the size and function of the remaining kidney in 53 survivors of Wilms' tumour with a mean off treatment follow-up of 13 years. There was evidence of renal dysfunction in 17 (32%), including ten (19%) with a low GFR (< 80 ml/min/1.73 m2SA), six (11%) with hypertension and five (9%) with increased urinary albumin excretion. Measurements of renal size showed 'good' renal compensatory hypertrophy in only 55% of patients. 'Good' refers to renal size of more than 2 s.d. above the mean renal length for children with two kidneys. There were no correlations between GFR, renal size, blood pressure, microalbuminuria or type of treatment. However, children less than 24 months at diagnosis and children receiving chemotherapy with radiation doses to remaining kidney of more than 1200 cGy had a worse renal prognosis. Patients whose Wilms' tumour is diagnosed in infancy should have careful long-term follow-up of renal function and size. Older patients may safely be followed up less often, unless their remaining kidney was received > 1200 cGy.
既然大多数肾母细胞瘤患者已被治愈,那么研究其治疗的长期发病率并利用这些信息来减少未来的治疗后遗症是可行的。在本研究中,我们评估了53例肾母细胞瘤幸存者剩余肾脏的大小和功能,这些患者治疗后的平均随访时间为13年。有17例(32%)存在肾功能不全的证据,其中10例(19%)肾小球滤过率低(<80 ml/min/1.73 m²体表面积),6例(11%)患有高血压,5例(9%)尿白蛋白排泄增加。肾脏大小测量显示只有55%的患者有“良好”的肾脏代偿性肥大。“良好”是指肾脏大小超过双侧肾脏儿童平均肾长的2个标准差以上。肾小球滤过率、肾脏大小、血压、微量白蛋白尿或治疗类型之间均无相关性。然而,诊断时年龄小于24个月的儿童以及接受化疗且剩余肾脏接受的辐射剂量超过1200 cGy的儿童,其肾脏预后较差。在婴儿期被诊断为肾母细胞瘤的患者应仔细进行肾功能和肾脏大小的长期随访。年龄较大的患者除非其剩余肾脏接受的辐射剂量>1200 cGy,否则可以减少随访频率。